Free tool
Dividend paying stocks
We cover 26 companies that currently pay a dividend. The median market value in the group is $204.86B. Across the group, the median move over the past trading day is +1.19%. 50% of the 26 with a 200-day average trade above it. Price change over the past year runs from −27.2% to +59.5% across the middle 80 percent of the group, with a median of +0.3%.
Other lists in this group
Table
26 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% |
| OMDA.OL | Omda AS | $81.21M | Micro cap | −23.98% |
| GENT.OL | Gentian Diagnostics ASA | $65.68M | Micro cap | −30.41% |
| AJ91.DE | DocCheck AG | $64.48M | Micro cap | −9.92% |
| HVO.L | hVIVO plc | $59.87M | Micro cap | −35.00% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| SVS.MI | Svas Biosana S.p.A. | $50.68M | Micro cap | +0.98% |
| M3V.DE | MeVis Medical Solutions AG | $50.50M | Micro cap | −0.42% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| X74.F | I.M.D. International Medical Devices S.p.A. | $20.60M | Micro cap | −22.17% |
| GME.DE | Geratherm Medical AG | $15.65M | Micro cap | −16.50% |
| PHR.WA | Pharmena S.A. | $9.45M | Micro cap | −8.72% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.